Semaglutide: A Revolutionary GLP-1 Receptor Agonist
Semaglutide, an agonist of the glucagon-like peptide-1 (GLP-1) receptor, has been making waves in the field of experimental studies, with researchers touting it as a revolutionary compound. The modest 30 amino acid incretin hormone, GLP-1, has shown significant activity, particularly…
Diabetes Drug Shows Promise in Protecting Against Colorectal Cancer
A recent analysis by researchers in the US suggests that a drug commonly used to treat type 2 diabetes could also be effective in protecting against colorectal cancer (CRC). The drug, known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), has…
Tirzepatide vs. Semaglutide: A Comparison
There has been a lot of buzz in the weight loss space with the emergence of medications like tirzepatide and semaglutide. But what’s the deal with tirzepatide vs. semaglutide? Let’s dive into the details. At a basic level, tirzepatide, also…